Oncology Experts

James R. Mcnab

JR. Corporate Governance and Nominating Committee
Titan Pharmaceutical Machinery
United States of America


JAMES R. MCNAB, JR. Corporate Governance and Nominating Committee Mr. McNab, an entrepreneur experienced in building and growing companies, is co-founder and chairman of Curis, a publicly traded oncology company that partnered with Roche to develop and commercialize a first-in-class hedgehog inhibitor for the treatment of advanced basal cell carcinoma. Mr. McNab serves as CEO and chairman of Palmetto Pharmaceuticals, executive chairman of FirstString Research Inc., and chairman of JT Pharmaceuticals. Previously Mr. McNab was founder of Vidus Ocular, a glaucoma device company that was sold to OPKO Health, and co-founder of Sontra Medical, which developed a medical low frequency ultrasound device from Massachusetts Institute of Technology that was sold to Echo Therapeutics.  

Research Interest


Global Experts from United States of America

Global Experts in Subject

Share This Profile